VRDN
Viridian Therapeutics Inc
19.40$
+2.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | +0.0% | +0.0% | +19.4% | -16.3% | +0.0% | +4.2% | +93,993.3% | -99.8% | +6.8% | +101.4% | – | |
| – | +4.5% | -1.4% | +1,578.6% | – | – | – | – | – | – | -62.2% | -3.3% | – | |
| – | +0.0% | +0.0% | +0.0% | +19.4% | -16.3% | +0.0% | +4.2% | +93,993.3% | -100.3% | – | +101.4% | – | |
| – | +26.9% | +6.2% | +37.2% | +23.1% | +4.1% | +6.8% | +12.7% | -0.4% | +3.4% | -13.0% | -7.8% | – | |
| – | +57.8% | -54.5% | +6.9% | -10.3% | +8.2% | +9.7% | +18.2% | +20.3% | +38.5% | +14.9% | +42.1% | – | |
| – | +39.5% | -21.8% | +29.1% | +15.6% | +4.8% | +7.3% | +13.7% | +3.5% | +10.8% | -5.1% | +8.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +52.7% | -35.9% | +1.7% | +68.2% | -14.5% | -31.7% | -12.3% | +8.9% | +1,080.0% | -47.6% | +139.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -102.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.